Bulut, T. Et Al. 2016. Omalizumab treatment decreased IL-1 beta and irisin but increased chemerin without any impact on NK cells and APC cells in cases of severe asthma. EAACI - European Academy of Allergy and Clinical Immunology congress , (Vienna, Austria), 257.

Bulut, T., Yalçın, A. D., Çelik, B., Genç, G. E., Köse, Ş., Göçmen, A. Y., ... Harman, R.(2016). Omalizumab treatment decreased IL-1 beta and irisin but increased chemerin without any impact on NK cells and APC cells in cases of severe asthma . EAACI - European Academy of Allergy and Clinical Immunology congress (pp.257). Vienna, Austria

Bulut, Tangül Et Al. "Omalizumab treatment decreased IL-1 beta and irisin but increased chemerin without any impact on NK cells and APC cells in cases of severe asthma," EAACI - European Academy of Allergy and Clinical Immunology congress, Vienna, Austria, 2016

Bulut, Tangül Et Al. "Omalizumab treatment decreased IL-1 beta and irisin but increased chemerin without any impact on NK cells and APC cells in cases of severe asthma." EAACI - European Academy of Allergy and Clinical Immunology congress , Vienna, Austria, pp.257, 2016

Bulut, T. Et Al. (2016) . "Omalizumab treatment decreased IL-1 beta and irisin but increased chemerin without any impact on NK cells and APC cells in cases of severe asthma." EAACI - European Academy of Allergy and Clinical Immunology congress , Vienna, Austria, p.257.

@conferencepaper{conferencepaper, author={Tangül Bulut Et Al. }, title={Omalizumab treatment decreased IL-1 beta and irisin but increased chemerin without any impact on NK cells and APC cells in cases of severe asthma}, congress name={EAACI - European Academy of Allergy and Clinical Immunology congress}, city={Vienna}, country={Austria}, year={2016}, pages={257} }